Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

Experimental drug shows evidence of lowering cholesterol, reducing risk of cardiovascular disease, and potentially treating lung cancer.

A drug being explored as a cardiovascular disease treatment may also reduce the risk of lung cancer.

Treatment with a Gβγ-GRK2 preserved the heart's function after a cardiac injury.

Niclosamide modifies a signaling pathway crucial for the survival of colon cancer cells.

Prophylactic mastectomy for ovarian cancer survivors with BRCA mutations may not improve survival.

Low-quality jobs observed to raise biomarkers of stress and adverse health events.

Top news of the day from across the healthcare landscape.

Hormone therapy is recommended to treat menopause symptoms, but is not recommended for breast cancer survivors.

Reference pricing may cause patients to be more aware of prescription drug costs.

The CDC gives an overview of several ways patients with diabetes can prevent diabetic foot ulcers and amputations.

Common treatment for acute chest infections called into question.

Breast cancer treatment may cause women to enter menopause prematurely.

Hypoglycemia-related hospitalizations are common among patients with type 2 diabetes.

Walnuts may promote fullness and healthy eating habits.

Top news of the day from across the healthcare landscape.

One-third of insured cancer patients may pay more out-of-pocket for treatment than expected.

Inhibiting heparanase observed to inhibit medulloblastoma cells.

Prescribing metformin for prediabetes could reduce healthcare costs by $820 million annually.

FilmArray can identify the underlying cause of illnesses within 1 hour of testing.

Inhibiting heparanase observed to inhibit medulloblastoma cells.

Top news of the day from across the healthcare landscape.

A first-in-class selective retinoic acid receptor alpha agonist is being tested in phase 2 clinical trials for acute myeloid leukemia and myelodysplastic syndrome.

Collaborative communication may improve medication adherence among low-income patients with high blood pressure.

Drugs that treat autoimmune disorders and hepatitis C virus power specialty drug spending.

Novel first-in-class selective retinoic acid receptor alpha agonist inhibits tumor growth in acute myeloid leukemia.

Quality of life found to be similar for patients with Parkinson’s disease who received in-office versus telemedicine-based care.

High exposure to fine particulate matter found to increase biomarkers for inflammation and oxidative stress.

It may be possible to retrain the immune system to prevent or slow attacks on insulin-producing beta cells.

Specialty drugs represent highest grossing prescription drugs of 2016.